Miriam Fried

Title: Miriam Fried: Innovator in Gene Targeting Technology

Introduction

Miriam Fried is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of genetic engineering, particularly in the area of gene targeting technology. Her innovative work has implications for immunotherapy and genetic research.

Latest Patents

Miriam Fried holds a patent for her invention titled "Recombination activating gene (RAG) induced V(D)J gene targeting." This invention relates to methods for the targeted insertion of nucleic acid sequences into a target genomic locus of a mammalian cell. The methods utilize nucleic acid cassettes that include recognition signal sequences for the insertion process, which is mediated by RAG-catalyzed recombination. The invention also encompasses cassettes, vectors, vehicles, and cells that incorporate these cassettes, along with their compositions and applications in immunotherapy. She has 1 patent to her name.

Career Highlights

Miriam Fried is affiliated with Tel Aviv University, where she conducts her research and development activities. Her work at the university has positioned her as a key figure in the advancement of genetic engineering techniques.

Collaborations

Miriam has collaborated with notable colleagues, including Adi Barzel and Iris Dotan, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Miriam Fried's contributions to gene targeting technology exemplify her innovative spirit and dedication to advancing scientific knowledge. Her work continues to influence the fields of genetics and immunotherapy, showcasing the importance of her inventions in modern science.